About
Ophthalmic Sciences has developed the IOPerfect, a contact-free, image processing-based intraocular pressure (IOP) measurement device designed for in-home telemedicine. Using a VR-like headset, the mobile product uses artificial intelligence algorithms to analyze captured video imaging and provide fast, reliable, user-friendly measurement of IOP, a key biomarker for monitoring and treating glaucoma.
Patients can easily and safely wear the smart headset to monitor their IOP at home anytime. Controlled air pressure is released over the patient's eyes, and a micro-video camera captures the difference in response to pressure on the internal versus the external blood vessels. An AI algorithm then analyzes the processed video to calculate the patient's IOP. The results are immediately delivered to a cloud-based app for telediagnosis by clinicians.
The company's tonometer solution enables highly accurate asynchronous remote monitoring, helping ophthalmologists and optometrists save time while improving patient outcomes and reducing costs for clinics, hospitals, and telehealth providers.
Ophthalmic Sciences is a portfolio company of eHealth Ventures.
Funding history · 3 rounds · $2.3M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary product developed by Ophthalmic Sciences?
- Ophthalmic Sciences developed the IOPerfect, a contact-free, image processing-based device for measuring intraocular pressure (IOP) designed for in-home telemedicine.
- When was Ophthalmic Sciences founded?
- Ophthalmic Sciences was founded in August 2019.
- What is the current operational status of Ophthalmic Sciences?
- As of January 2025, Ophthalmic Sciences is inactive and has ceased to operate.
- What was the total amount of funding raised by Ophthalmic Sciences?
- Ophthalmic Sciences raised a total of $2,320,000 across its funding rounds.
- Which investor participated in Ophthalmic Sciences' Pre-Seed round in October 2019?
- The Israel Innovation Authority and eHealth Ventures invested in Ophthalmic Sciences' Pre-Seed round in October 2019.
- When did Ophthalmic Sciences secure its $1.1 million Seed financing round?
- Ophthalmic Sciences secured a $1.1 million Seed financing round in January 2022, with eHealth Ventures as an investor.
- When did Ophthalmic Sciences begin recruitment for clinical testing of its advanced prototype?
- In November 2022, Ophthalmic Sciences initiated recruitment at Assuta Hashalom for clinical testing of its most advanced prototype.
- What is the employee count for Ophthalmic Sciences?
- Ophthalmic Sciences has 3 employees.
- What technology does the IOPerfect device utilize for IOP measurement?
- The IOPerfect device uses a VR-like headset with artificial intelligence algorithms to analyze captured video imaging for IOP measurement.